ReviewPostepy dermatologii i alergologii2023

Efficacy and safety of upadacitinib for the treatment of moderate-to-severe atopic dermatitis: a meta-analysis of randomized clinical trials.

Linxi Zeng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.